BiotechTube
MMS Holdings

MMS Holdings

Canton, United States· Est.
mmsholdings.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15M

Overview

Founded in 2004, MMS Holdings is a privately held, revenue-generating services company headquartered in Canton, Michigan, USA. It operates as a specialized CRO with a core focus on leveraging data, artificial intelligence, and technology to accelerate and de-risk clinical development and regulatory submissions for its clients. The company's value proposition centers on its Datacise® technology suite, proven regulatory track record with zero refusals to file, and a flexible service model that includes full-service and Functional Service Provider (FSP) engagements.

Rare DiseasesOncologyCentral Nervous System (CNS) DisordersPsychedelicsRadiopharmaceuticals

Technology Platform

Datacise® suite: A flexible, evolving toolkit leveraging AI and machine learning for clinical trial acceleration. Use-cases include IDMC management, safety signal detection, data flow management, and near real-time trial insights. Includes KerusCloud® for clinical trial simulation.

Funding History

1
Total raised:$15M
Series A$15M

Opportunities

The growing complexity of clinical trials and the rapid adoption of AI/ML in drug development create a significant opportunity for MMS's specialized, technology-enabled services.
Increased regulatory scrutiny and sponsor demand for faster, more efficient approval pathways further play to the company's core strengths in regulatory strategy and submissions.

Risk Factors

MMS operates in the highly competitive CRO market against larger, full-service players and faces execution risk related to its technology platform.
Its business is also subject to cyclicality based on biopharma R&D spending and carries inherent regulatory compliance risk given its focus on submissions.

Competitive Landscape

MMS competes with large, full-service CROs (e.g., IQVIA, ICON, Labcorp) and a fragmented landscape of niche biometrics, regulatory, and technology-focused service providers. Its differentiation lies in its integrated 'data-focused' model, proprietary Datacise® platform, and strong regulatory submission track record.

More companies in Digital Health & Biotech SaaS →More companies in United States →